(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRANSFORM DIABETES CARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRANSFORM DIABETES CARE

ST13

US500000087266941

Class

35, 36, 44

Filing

87266941

Registration

5509284

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

12/02/2024

Trademark type

Word

Nice classes

35, 36, 44

Filing date

12/13/2016

Registration date

07/03/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/02/2024

Last transaction

12/02/2024

Responsible office

United States Patent and Trademark Office

Status code

705

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/13/2016

First use in commerce

12/13/2016

Drawing code

4

Owner type

03

Owner location

Woonsocket, RI

Examiner

RICHARDS, LESLIE

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CVS Pharmacy, Inc.

Representatives

Erich G. Rhynhart CVS Pharmacy, Inc.

Technical classification

Nice Classes

Class 35Class 36Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy services; mail order of pharmaceuticals; specialty pharmaceutical distributorship servicesdistributorships featuring pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; pharmaceutical utilization review services; prescription drug formulary cost and business management servicesclinical and cost-effectiveness reviews following evidence-based medicine and incorporation of value-based criteria into formulary designs; Business administration of pharmacy reimbursement programs and services

Class 36

Pharmacy benefit management services; insurance claims processing of pharmaceutical benefits; Financial administration of pharmacy reimbursement programs and services

Class 44

Therapeutic pharmaceutical servicesdispensing of pharmaceuticals and counseling on medicationsincorporating disease monitoring services and clinical reviews; Pharmaceutical advice; disease management programs

Publications

History of USPTO decisions and trademark events.

32 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/02/2024

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/02/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/02/2024

E815

TEAS SECTION 8 & 15 RECEIVED

06/21/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/03/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/03/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/26/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/25/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/09/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/08/2018

IUAF

USE AMENDMENT FILED

04/18/2018

EISU

TEAS STATEMENT OF USE RECEIVED

04/18/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/24/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/29/2017

PUBO

PUBLISHED FOR OPPOSITION

08/29/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/09/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/20/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

07/19/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/19/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

07/19/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/19/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/27/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/27/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/27/2017

CEPE

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED

01/12/2017

ALIE

ASSIGNED TO LIE

01/12/2017

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

01/12/2017

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

01/12/2017

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

01/12/2017

DOCK

ASSIGNED TO EXAMINER

01/05/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/19/2016

NWAP

NEW APPLICATION ENTERED

12/16/2016

Continuous trademark protection

Get notified about every new filing that threatens TRANSFORM DIABETES CARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.